These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter. Kim HY; Choi BS; Kim SS; Roh TY; Park J; Yoon CH Retrovirology; 2014 Aug; 11():67. PubMed ID: 25116364 [TBL] [Abstract][Full Text] [Related]
10. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication. Chen H; He J; Fong S; Wilcox G; Wood C J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286 [TBL] [Abstract][Full Text] [Related]
11. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. Chauhan A; Turchan J; Pocernich C; Bruce-Keller A; Roth S; Butterfield DA; Major EO; Nath A J Biol Chem; 2003 Apr; 278(15):13512-9. PubMed ID: 12551932 [TBL] [Abstract][Full Text] [Related]
12. Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism. Díaz L; Martínez-Bonet M; Sánchez J; Fernández-Pineda A; Jiménez JL; Muñoz E; Moreno S; Álvarez S; Muñoz-Fernández MÁ Sci Rep; 2015 Jul; 5():12442. PubMed ID: 26199173 [TBL] [Abstract][Full Text] [Related]
13. Transactivation of heterologous promoters by HIV-1 tat. Han P; Brown R; Barsoum J Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814 [TBL] [Abstract][Full Text] [Related]
14. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation. Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485 [TBL] [Abstract][Full Text] [Related]
15. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat. Chakraborty S; Kabi M; Ranga U J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338 [TBL] [Abstract][Full Text] [Related]
16. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants. de Arellano ER; Alcamí J; López M; Soriano V; Holguín A Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine. Jiang MC; Lin JK; Chen SS Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583 [TBL] [Abstract][Full Text] [Related]
18. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat. Di Luca D; Secchiero P; Bovenzi P; Rotola A; Caputo A; Monini P; Cassai E AIDS; 1991 Sep; 5(9):1095-8. PubMed ID: 1657039 [TBL] [Abstract][Full Text] [Related]
19. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat. Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029 [TBL] [Abstract][Full Text] [Related]
20. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]